Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

Market Cap	30.40M +6.7%
Revenue (ttm)	17.40M +7.3%
Net Income	2.33M -22.5%
EPS	0.25 -23.3%
Shares Out	9.50M
PE Ratio	13.05
Forward PE	n/a
Dividend	0.19 (6.01%)
Ex-Dividend Date	Apr 16, 2026

Volume	1,066
Open	3.180
Previous Close	3.170
Day's Range	3.180 - 3.200
52-Week Range	2.920 - 3.550
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About ASE:HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and sale of pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 246
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2025, ASE:HPIC's revenue was 17.11 million, an increase of 2.39% compared to the previous year's 16.71 million. Earnings were 2.31 million, a decrease of -25.29%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 28, 2026

Data Sources Report a data error